225Ac-PD-29875

N/A

Report date: 2025/11/20 16:03:45

NME

Base Information

Drug Name225Ac-PD-29875

Drug Alias Name225Ac-CLDN18.2225Ac-PD-29875

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionCarbonic anhydrase IX inhibitors

TargetsCarbonic anhydrase IX

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPeptiDream Inc

China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream Inc

Inactive CompaniesN/A

Active IndicationsStomach Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A